DiviDrip · GTBP

GTBP — GT Biopharma, Inc.

GTBP is GT Biopharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.24. Market cap: $11M. Capital Quality Rank: 14/100 — Capital destroyer.

Stock snapshot

Price$0.24
Market cap$11M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)14 / 100 · Capital destroyer
Shareholder buyback yield-7.25%
Altman Z-score zoneDistress

About GTBP

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Listed2021Employees1HQSan Francisco, CASectorHealthcareWebsitegtbiopharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside GTBP. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is GTBP's current stock price?

GTBP (GT Biopharma, Inc.) is currently trading at $0.24.

Does GTBP pay a dividend?

GTBP (GT Biopharma, Inc.) does not currently pay a regular dividend.

What is GTBP's Capital Quality Rank?

GTBP has a Capital Quality Rank of 14/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track GTBP in DiviDrip

Add GTBP to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow